Testing a non-invasive smartphone application to predict sugar levels in the blood

Not Applicable

• Conditions: Type 2 diabetes; Nutritional, Metabolic, Endocrine

• Registration Number: ISRCTN15977623
• Lead Sponsor: Bioepic Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-06-27
• Last Update Posted: 5 August 2022
• Study Completion: 2022-12-31

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 72

Inclusion Criteria

Type 2 diabetes

Exclusion Criteria

1. Body mass index < 18.5 kg/m2
2. Pregnancy or lactating
3. Participation in any clinical study during the previous 2 months
4. Any other condition that in the opinion of the investigator would interfere with the evaluation of the study results or constitute a health risk for the participant
5. Any medication that in the opinion of the investigator would interfere with the evaluation of the study results
6. Recreational or illicit drug intake
7. Individuals who fail to utilise the Smartphone App appropriately
8. Aversion to the sight of blood
9. Severe coronary heart disease
10. Participants with known uncontrolled hypertension (i.e. >160mmHg systolic or >95 mmHg diastolic)
11. Severe renal impairment (eGFR<15ml/min)

Study & Design

• Study Type: Observational
• Study Design: Not specified